Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia
NCT ID: NCT01902602
Last Updated: 2020-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
19 participants
OBSERVATIONAL
2013-08-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In addition, data are collected on the immune system as well as for food and sleep quality.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistant Hypertension and Physical Activity Performed in a Heated Pool
NCT01863082
Treatment of Hypertension: an Interventional Approach to Improve Blood Pressure Control
NCT02362893
Management of Uncontrolled Hypertension (HTN)
NCT02922023
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
NCT03042988
Temperature-elevating Armbaths for Arterial Hypertension
NCT05928702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inclusion age : 45 +
* Regular monitoring of blood levels considered
* pre-medication to lower blood pressure for at least 3 weeks before the preliminary investigation consistent
* Men and Women
Exclusion Criteria
* renal impairment , renal creatinine clear \<50 ml
* Non - austherapierte cancer / tumor patients
* Non - adjusted thyroid dysfunction
* BMI\> 35
* LVEF \<limit ( " 35% " )
* Peripheral AVK ( ABI - measurement ) \> Stage II
* regurgitation \> Stage I
* abdominal aneurysm
* infections
* acute febrile infections with temperature \> 38.5 ° C
* COPD and asthma to stage III
* dyspnea NYHA \> Stage III
* z.n. Stroke shorter than 12 weeks
* Acute liver failure
* Acute Apoplexy
* Severe poisoning
* drug addiction
* hyperthyroidism
* Hypotension
* hypocalcemia
* hypoglycemia
* ozone allergy
* pregnancy
* clotting problems ( hemophilia )
* pre-existing condition with hemoglobin \< 9mg/dl
* Fresh myocardial infarction
* Internal bleeding
* thrombocytopenia
* Acute alcohol
* Citrus allergy when using sodium citrate
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herrmann Apparatebau GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Panos Porikis, Phd
Role: PRINCIPAL_INVESTIGATOR
unafflicated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Panos Porikis
Biblis, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HAB10-2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.